zonisamide has been researched along with Abdominal Migraine in 10 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide is an antiepileptic drug used as adjunctive therapy for refractory partial seizures in adults." | 6.43 | Zonisamide: review of its use in epilepsy therapy. ( Zareba, G, 2005) |
| "Persistent migraine aura without infarction is a rare but debilitating condition." | 5.62 | Zonisamide as treatment option in persistent migraine aura. ( Broessner, G; Frank, F; Kaltseis, K, 2021) |
| "On the basis of six randomized controlled trials, zonisamide (ZNS) can be prescribed as add-on treatment in focal adulthood epilepsy in USA and Europe." | 4.85 | [Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases]. ( Janszky, J, 2009) |
| "The pathophysiology of pain in migraine is related to the activation of the trigeminovascular system by releasing vasoactive neuropeptides, the most important of which is calcitonin gene-related peptide (CGRP), which causes a neurogenic inflammation in the leptomeningeal vessels." | 2.84 | [Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide]. ( Garcia-Estevez, DA; Pardo-Parrado, M; Silvarrey-Rodriguez, S, 2017) |
| "One hundred and twenty migraineurs who were refractory to topiramate were recruited." | 2.79 | Efficacy of zonisamide in migraineurs with nonresponse to topiramate. ( Chung, JY; Kim, M; Kim, MW, 2014) |
| "Zonisamide is an antiepileptic drug used as adjunctive therapy for refractory partial seizures in adults." | 2.43 | Zonisamide: review of its use in epilepsy therapy. ( Zareba, G, 2005) |
| "Persistent migraine aura without infarction is a rare but debilitating condition." | 1.62 | Zonisamide as treatment option in persistent migraine aura. ( Broessner, G; Frank, F; Kaltseis, K, 2021) |
| "Zonisamide is a relatively new sulfonamide derivative indicated for epilepsy and used off-label for migraines." | 1.42 | Zonisamide-induced angle closure and myopic shift. ( Weiler, DL, 2015) |
| "Zonisamide was well tolerated, only 4 (12%) patients reported transient and tolerable side effects." | 1.37 | Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study. ( Ciuffoli, A; Prosperini, L; Sette, G; Villani, V, 2011) |
| "Zonisamide is an antiepileptic drug with preliminary studies suggesting some efficacy in the adult headache population." | 1.33 | Zonisamide prophylaxis in refractory pediatric headache. ( Kring, D; Pakalnis, A, 2006) |
| "Zonisamide is a new antiepileptic drug with multiple mechanisms of action and a favourable pharmacokinetic profile." | 1.33 | Zonisamide for migraine prophylaxis in refractory patients. ( Ashkenazi, A; Benlifer, A; Korenblit, J; Silberstein, SD, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaltseis, K | 1 |
| Frank, F | 1 |
| Broessner, G | 1 |
| Garcia-Estevez, DA | 1 |
| Pardo-Parrado, M | 1 |
| Silvarrey-Rodriguez, S | 1 |
| Chung, JY | 1 |
| Kim, MW | 1 |
| Kim, M | 1 |
| Jion, YI | 1 |
| Raff, A | 1 |
| Grosberg, BM | 1 |
| Evans, RW | 1 |
| Weiler, DL | 1 |
| Janszky, J | 1 |
| Villani, V | 1 |
| Ciuffoli, A | 1 |
| Prosperini, L | 1 |
| Sette, G | 1 |
| Zareba, G | 1 |
| Pakalnis, A | 1 |
| Kring, D | 1 |
| Ashkenazi, A | 1 |
| Benlifer, A | 1 |
| Korenblit, J | 1 |
| Silberstein, SD | 1 |
3 reviews available for zonisamide and Abdominal Migraine
| Article | Year |
|---|---|
The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension.
Topics: Adult; Anticonvulsants; Female; Fructose; Humans; Isoxazoles; Kidney Calculi; Migraine Disorders; Ps | 2015 |
[Role of zonisamid in treating epilepsy, Parkinson disorders and other neurological diseases].
Topics: Anticonvulsants; Bipolar Disorder; Calcium Channels, T-Type; Cholinergic Agents; Dopamine Agents; Dy | 2009 |
Zonisamide: review of its use in epilepsy therapy.
Topics: Animals; Anticonvulsants; Biological Availability; Child; Child, Preschool; Drug Interactions; Epile | 2005 |
2 trials available for zonisamide and Abdominal Migraine
| Article | Year |
|---|---|
[Frequent episodic migraine and calcitonin gene-related peptide. Influence of treatment with topiramate and zonisamide on levels of the peptide].
Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Female; Fructose; Humans; Isoxazoles; Male; Middle Age | 2017 |
Efficacy of zonisamide in migraineurs with nonresponse to topiramate.
Topics: Adult; Female; Fructose; Headache; Humans; Isoxazoles; Male; Middle Aged; Migraine Disorders; Parest | 2014 |
5 other studies available for zonisamide and Abdominal Migraine
| Article | Year |
|---|---|
Zonisamide as treatment option in persistent migraine aura.
Topics: Adolescent; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Humans; Migraine Diso | 2021 |
Zonisamide-induced angle closure and myopic shift.
Topics: Acute Disease; Adult; Anticonvulsants; Female; Glaucoma, Angle-Closure; Gonioscopy; Humans; Intraocu | 2015 |
Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.
Topics: Adult; Anticonvulsants; Female; Follow-Up Studies; Fructose; Humans; Incidence; Isoxazoles; Middle A | 2011 |
Zonisamide prophylaxis in refractory pediatric headache.
Topics: Adolescent; Anticonvulsants; Child; Drug Resistance; Female; Humans; Isoxazoles; Male; Medical Recor | 2006 |
Zonisamide for migraine prophylaxis in refractory patients.
Topics: Adult; Anticonvulsants; Drug Resistance; Female; Humans; Isoxazoles; Male; Middle Aged; Migraine Dis | 2006 |